Menu
Log In Sign Up
Article

ae 105 peptide characterize a new variant of AE105

Published October Oct 18, 2026 7:23 AM

In the evolving field of peptide research, the AE 105 peptide stands out as a foundational molecule, primarily recognized for its high affinity for the urokinase-type plasminogen activator receptor (uPAR). As an enthusiast following the latest developments in molecular science, I have found that exploring the structural nuances of such ligands provides deep insight into how synthetic chains can be optimized for specific binding targets.

The Structural Foundation of AE 105

The original AE 105 sequence (Asp-Cha-Phe-(d)Ser-(d)Arg-Tyr-Leu-Trp-Ser-C TnP Peptide Suppresses Experimental Autoimmune ONH2) serves as a classic example of how linear peptide architecture can be refined. Researchers have worked to improve the stability of this molecule by constraining its conformational landscape. One of the most successful approaches has been disulfide-mediated cyclization, which transforms the core structure into a more rigid, targeted entity.

For those of us tracking these developments, it is fascinating to see how the modification of essential amino acids—specifically the Phe/Glu and Trp/Glu residues—can render the molecule inactive, highlighting the precision required in peptide synthesis.

Innovations in Conjugation and Imaging

The versatility of the AE 105 scaffold has led to the creation of various radiopeptides. By utilizing chelators such as DOTA, NOTA, NODAGA, and HBED-CC, scientists have successfully developed 68Ga-labeled AE 105 peptide conjugates. These are often studied as PET-probes, providing a high-contrast look at Empty peptide-receptive MHC class I molecules for efficient uPAR expression.

Beyond radioactive labeling, I have been following the progress of optical imaging variants, such as ICG-Glu-Glu-AE105. This specific variant demonstrates how adding linker sequences can enhance the pharmacokineti 68Ga-labeled HBED-CC Variant of uPAR Targeting c profile of the base peptide, allowing for better visualization in experimental models. It is a prime example of why we develop novel AE 105-based radiopeptides: to achieve higher specificity and lower background interference.

Navigating the Landscape of "105" Peptides

It is important to distinguish AE 105 from other similarly named molecules that appear in current literature. For instance, the apolipoprotein E mime Design and Preclinical Evaluation of Novel uPAR-Targeting tic peptide CN-105 is fr Ea52-68 peptide bound to I-Ab Monoclonal Antibody equently discussed in contexts involving the central nervous system. CN-105 represents an apoE mimetic peptide that showcases pot by D Beyer · 2025 · Cited by 4 — The aim of this study was to develop novel AE105-based radiopeptides modified with an albumin-binding entity to enhance their pharmacokinetic  ential for neuroprotection, which is quite distinct from the uPAR-targeting functions of our primary subject.

Furthermore, we often see C105Y peptide cited in studies regarding cell-penetrating properties and gene transfer efficac Fluorescence spectra of ICG (blue) and ICG-Glu-Glu-AE105 (green) measured in HBC solution. The noise observed between 860–900 nm in the fluorescence spectra are  y, as well as peptide H105A, which has been noted for its role in supporting photoreceptor survival. While the number 105 links these entities, their biological pathway by A Chopra · 2012 · Cited by 2 — A radiolabeled linear peptide that has a high affinity for the uPAR, AE105 (Asp-Cha-Phe-(d)Ser-(d)Arg-Tyr-Leu-Trp-Ser-CONH2), is considered to  s and intended applications are vastly different. Additionally, the azelaprag (BGE-105) molecule has recently garnered attention for its cardioprotective effects, further highlighting the diversity of compounds under this numerical designation.

Broader Context in Peptide Research

My interest in these molecules often leads me to explore how they fit into the larger ecosystem of bio-active chains. From multi-targeting macrocyclic peptides that inhibit amyloid self-assembly to the TnP peptide that exhibits disease-suppressive functions in EAE models, the range of current research is immense. Even natural extracts, such as the 28-residue Avt1 peptide derived from sea anemones, contribute to our understanding of inhibitory cystine knot motifs.

Final Thoughts for Enthusiasts

Whether you are interested in the synthesis of a multifunctional antibiotic-host defense peptide conjugate or simply analyzing the binding affinity of the Ae-related sequences, the field remains a testament to human ingenuity. The ability to manipulate sequences to achieve such high specificity is why I continue to follow the literature on these complex amino acid chains. Always ensure that your interest in these research materials remains strictly within the bounds of academic inquiry and experimental observation.

Leave a Comment
Get new articles in your inbox

News, updates and freebies. No spam, unsubscribe anytime.